Natixis Investment Managers International’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Natixis Investment Managers International's DGX Position: Q2 2022 in Review
Natixis Investment Managers International sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 3,832 shares — an estimated $524K sold.
Natixis Investment Managers International first reported a position in DGX in Q4 2016 and held it in 7 quarters. The position peaked at $886K in Q2 2018. 852 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Natixis Investment Managers International reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 3,832 Quest Diagnostics shares in Q2 2022, an estimated $524K.
- Natixis Investment Managers International first reported a position in Quest Diagnostics in Q4 2016 and held it in 7 quarters.
- Natixis Investment Managers International's Quest Diagnostics position peaked at $886K in Q2 2018.
- 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Natixis Investment Managers International's 13F filing for Q2 2022, filed 12 Aug 2022.